Sign in

CIK 0001069899 · Large accelerated filer

PHIBRO ANIMAL HEALTH CORP

Sign in to watch
Ticker
PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
131840497
Phone
201-329-7300
Business address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
Former names
PHILIPP BROTHERS CHEMICALS INC
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 4 Planned sale President and CEO sold 5,752 shares at an average $40.93 ($235,405)
  3. 4 Planned sale President and CEO sold 4,808 shares at an average $40.10 ($192,781)
  4. 4 Planned sale President and CEO sold 7,040 shares at an average $41.00 ($288,607)
  5. 144 Insider Sale of Securities
  6. 4 Planned sale President and CEO sold 7,040 shares at an average $42.10 ($296,376)
  7. 4 Planned sale President and CEO sold 12,320 shares at an average $43.97 ($541,674)
  8. 4 Planned sale President and CEO sold 3,520 shares at an average $41.76 ($147,002)
  9. 4 Planned sale President and CEO sold 10,560 shares at an average $44.19 ($466,631)
  10. 4 Planned sale President and CEO sold 30,337 shares at an average $45.01 ($1,365,393)
  11. 4 Planned sale President and CEO sold 41,823 shares at an average $45.09 ($1,885,618)
  12. 4 Planned sale President and CEO sold 7,040 shares at an average $42.16 ($296,778)
  13. 8-K Event Results of operations · Shareholder vote results
  14. 10-Q Report Quarterly Report
  15. 8-K Event Other events
  16. 4 Planned sale President and CEO sold 10,560 shares at an average $41.43 ($437,487)
  17. 4 Planned sale President and CEO sold 18,899 shares at an average $40.53 ($765,941)
  18. 4 Planned sale President and CEO sold 16,775 shares at an average $40.37 ($677,198)
  19. 4 Planned sale President and CEO sold 20,664 shares at $40.38 ($834,412)
  20. 4 Planned sale President and CEO sold 7,022 shares at $40.26 ($282,732)

Page 5 of 39 · 774 filings